Home/Filings/4/0001209191-19-017822
4//SEC Filing

Williams Anthony L 4

Accession 0001209191-19-017822

CIK 0001237831other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 5:07 PM ET

Size

37.1 KB

Accession

0001209191-19-017822

Insider Transaction Report

Form 4
Period: 2019-03-05
Williams Anthony L
Senior VP of Bus. Devel. & GC
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2019-03-06$26.27/sh+5,507$144,6698,386 total
  • Exercise/Conversion

    Class A Common Stock

    2019-03-07$26.27/sh+37,826$993,68937,826 total
  • Sale

    Class A Common Stock

    2019-03-07$46.01/sh37,826$1,740,3740 total
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2019-03-0547,50012,500 total
    Exercise: $25.52Exp: 2026-01-25Class A Common Stock (47,500 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2019-03-058,3330 total
    Exercise: $24.10Exp: 2025-01-20Class A Common Stock (8,333 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2019-03-05$25.65/sh+89,583$2,297,80489,583 total
  • Exercise/Conversion

    Class A Common Stock

    2019-03-05$25.52/sh+47,500$1,212,200137,083 total
  • Exercise/Conversion

    Class A Common Stock

    2019-03-05$43.77/sh+20,454$895,272157,537 total
  • Exercise/Conversion

    Class A Common Stock

    2019-03-05$24.10/sh+8,333$200,825165,870 total
  • Sale

    Class A Common Stock

    2019-03-05$47.05/sh165,870$7,804,1830 total
  • Exercise/Conversion

    Class A Common Stock

    2019-03-06$43.77/sh+2,879$126,0142,879 total
  • Sale

    Class A Common Stock

    2019-03-06$46.14/sh8,386$386,9300 total
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2019-03-0589,58310,417 total
    Exercise: $25.65Exp: 2025-07-07Class A Common Stock (89,583 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2019-03-0520,45459,546 total
    Exercise: $43.77Exp: 2028-01-22Class A Common Stock (20,454 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2019-03-062,87956,667 total
    Exercise: $43.77Exp: 2028-01-22Class A Common Stock (2,879 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2019-03-065,50774,493 total
    Exercise: $26.27Exp: 2027-01-30Class A Common Stock (5,507 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2019-03-0737,82636,667 total
    Exercise: $26.27Exp: 2027-01-30Class A Common Stock (37,826 underlying)
Footnotes (8)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.80 to $47.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  • [F4]These options were granted on July 7, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 7, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F5]These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F6]These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F7]These options were granted on January 20, 2015, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F8]These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeother

Related Parties

1
  • filerCIK 0001635534

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:07 PM ET
Size
37.1 KB